Found: 20
Select item for more details and to access through your institution.
Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 7, p. 616, doi. 10.3390/cells13070616
- By:
- Publication type:
- Article
Efficacy and Safety of a Parenteral Nutrition Program for Patients with RAS Wild-Type Metastatic Colorectal Cancer Administered First-Line Cetuximab Plus Chemotherapy: A Propensity Score Matching Study.
- Published in:
- Nutrients, 2023, v. 15, n. 13, p. 2971, doi. 10.3390/nu15132971
- By:
- Publication type:
- Article
Long Non-Coding RNA MIR31HG Promotes the Transforming Growth Factor β-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 12, p. 6559, doi. 10.3390/ijms23126559
- By:
- Publication type:
- Article
HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells.
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 9, p. 2271, doi. 10.3390/ijms20092271
- By:
- Publication type:
- Article
Prevalence and prognostic influence of genomic changes of EGFR pathway markers in synovial sarcoma.
- Published in:
- Journal of Surgical Oncology, 2011, v. 103, n. 8, p. 773, doi. 10.1002/jso.21852
- By:
- Publication type:
- Article
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal Adenocarcinoma.
- Published in:
- Genes, 2019, v. 10, n. 10, p. 766, doi. 10.3390/genes10100766
- By:
- Publication type:
- Article
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.
- Published in:
- Oncology Letters, 2023, v. 26, n. 6, p. N.PAG, doi. 10.3892/ol.2023.14120
- By:
- Publication type:
- Article
Repositioning VU‐0365114 as a novel microtubule‐destabilizing agent for treating cancer and overcoming drug resistance.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 2, p. 386, doi. 10.1002/1878-0261.13536
- By:
- Publication type:
- Article
Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.
- Published in:
- Diagnostics (2075-4418), 2023, v. 13, n. 13, p. 2296, doi. 10.3390/diagnostics13132296
- By:
- Publication type:
- Article
Sequential Interferon β-Cisplatin Treatment Enhances the Surface Exposure of Calreticulin in Cancer Cells via an Interferon Regulatory Factor 1-Dependent Manner.
- Published in:
- Biomolecules (2218-273X), 2020, v. 10, n. 4, p. 643, doi. 10.3390/biom10040643
- By:
- Publication type:
- Article
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer Cells.
- Published in:
- Biomolecules (2218-273X), 2019, v. 9, n. 9, p. 467, doi. 10.3390/biom9090467
- By:
- Publication type:
- Article
Sudden-Onset Pancytopenia with Intracranial Hemorrhage after Oxaliplatin Treatment: A Case Report and Literature Review.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 125, doi. 10.1093/jjco/hyq162
- By:
- Publication type:
- Article
Taiwan Society of Colon and Rectal Surgeons Consensus on mCRC Treatment.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.764912
- By:
- Publication type:
- Article
High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1620, doi. 10.3390/cancers13071620
- By:
- Publication type:
- Article
ABL Genomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1399, doi. 10.3390/cancers12061399
- By:
- Publication type:
- Article
Bioinformatics Data Mining Repurposes the JAK2 (Janus Kinase 2) Inhibitor Fedratinib for Treating Pancreatic Ductal Adenocarcinoma by Reversing the KRAS (Kirsten Rat Sarcoma 2 Viral Oncogene Homolog)-Driven Gene Signature.
- Published in:
- Journal of Personalized Medicine, 2020, v. 10, n. 3, p. 130, doi. 10.3390/jpm10030130
- By:
- Publication type:
- Article
Comparing the effectiveness of different EGFR‐TKIs in patients with EGFR mutant non–small‐cell lung cancer: A retrospective cohort study in Taiwan.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 4, p. 1107, doi. 10.1002/ijc.32841
- By:
- Publication type:
- Article
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43006-z
- By:
- Publication type:
- Article
Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-43006-z
- By:
- Publication type:
- Article
Epidermal growth factor receptor R521 K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy.
- Published in:
- Cancer Science, 2012, v. 103, n. 4, p. 791, doi. 10.1111/j.1349-7006.2012.02225.x
- By:
- Publication type:
- Article